TrialPanorama/TrialPanorama-database huggingface dataset:
Study 23212438 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 27927064 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27927064 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27927064 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 8985622 — Surrogate Endpoint (SUR): Blood pressure
Study 16231757 — Surrogate Endpoint (SUR): Blood pressure
Study 7479629 — Surrogate Endpoint (SUR): Blood pressure
Study 18984660 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 24189519 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 24189519 — Surrogate Endpoint (SUR): Serum creatinine
Study 29093152 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25019571 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25019571 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 25019571 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25019571 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 25019571 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 25019571 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 22110164 — Surrogate Endpoint (SUR): Blood pressure
Study 17537764 — Surrogate Endpoint (SUR): Forced vital capacity
Study 17537764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 4042306 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 18528294 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 18528294 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 9273824 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9273824 — Surrogate Endpoint (SUR): Blood pressure
Study 28118307 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 24477778 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 24477778 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31939063 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 31939063 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 2676877 — Surrogate Endpoint (SUR): Blood pressure
Study 31299919 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 31299919 — Surrogate Endpoint (SUR): Serum calcium
Study 27859427 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 27859427 — Predictive Biomarker (PRD): DCT mRNA
Genes: DCT; TYRP2
Study 3882739 — Surrogate Endpoint (SUR): Serum testosterone
Study 27252245 — Surrogate Endpoint (SUR): Blood pressure
Study 22649265 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23979954 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29481425 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 24495641 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24495641 — Surrogate Endpoint (SUR): Blood pressure
Study 21663811 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 19801025 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 9594558 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 9594558 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study 9594558 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 9594558 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 31151228 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study 21414035 — Safety Biomarker (SAF): Hyaluronic acid
Study 15105027 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15105027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9589230 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 9589230 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 7990660 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2660451 — Surrogate Endpoint (SUR): Blood pressure
Study 21231888 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 15050696 — Safety Biomarker (SAF): Interleukin 1
Study 31571150 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 20399288 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 20399288 — Surrogate Endpoint (SUR): Bone mineral density
Study 10456461 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 31687396 — Predictive Biomarker (PRD): CYP1A1 mRNA
Genes: CYP1A1
Study 31687396 — Predictive Biomarker (PRD): CYP1B1 mRNA
Genes: CYP1B1
Study 31687396 — Safety Biomarker (SAF): Reactive oxygen species
Study 19856194 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9071954 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 16517955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29328027 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29328027 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11728260 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11728260 — Surrogate Endpoint (SUR): Serum creatinine
Study 11728260 — Surrogate Endpoint (SUR): Blood pressure
Study 29490302 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29490302 — Predictive Biomarker (PRD): Hormone receptor
Study 18525261 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 18525261 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 18525261 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 15996071 — Safety Biomarker (SAF): Interleukin 1
Study 29196963 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29196963 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21749167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19004198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1420996 — Safety Biomarker (SAF): Interleukin 1
Study 1420996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 4047702 — Surrogate Endpoint (SUR): Blood pressure
Study 30575804 — Predictive Biomarker (PRD): TSHR mRNA
Genes: TSHR; LGR3
Study 30575804 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 20130863 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 567008 — Surrogate Endpoint (SUR): Serum triglycerides
Study 567008 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 567008 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30888959 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 26089029 — Predictive Biomarker (PRD): SLC12A2 mRNA
Genes: SLC12A2; NKCC1
Study 26089029 — Predictive Biomarker (PRD): SLC12A1 mRNA
Genes: SLC12A1; NKCC2
Study 15611571 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 19996755 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study 15701590 — Safety Biomarker (SAF): Hyaluronic acid
Study 28385659 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 16581479 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 10770181 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 9395949 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 3602017 — Surrogate Endpoint (SUR): Blood pressure
Study 3602017 — Surrogate Endpoint (SUR): Serum potassium
Study 16201856 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 10334412 — Surrogate Endpoint (SUR): Blood pressure
Study 1697334 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 24158762 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 24158762 — Predictive Biomarker (PRD): OGG1 mRNA
Genes: OGG1; MMH; MUTM; OGH1
Study 24158762 — Predictive Biomarker (PRD): XPC mRNA
Genes: XPC; XPCC
Study 22920077 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 20133927 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17478068 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 17478068 — Surrogate Endpoint (SUR): Bone mineral density
Study 8595643 — Surrogate Endpoint (SUR): Blood pressure
Study 2914082 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 2914082 — Surrogate Endpoint (SUR): Blood pressure
Study 30582240 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30582240 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30582240 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27230861 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25487930 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23025735 — Surrogate Endpoint (SUR): Blood pressure
Study 18728281 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12072043 — Surrogate Endpoint (SUR): Blood pressure
Study 1841609 — Surrogate Endpoint (SUR): Blood pressure
Study 25182045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25182045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25182045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25208464 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 22764762 — Predictive Biomarker (PRD): Hormone receptor
Study 19354088 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 19354088 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 11356434 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28992899 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 25882864 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 25882864 — Surrogate Endpoint (SUR): Blood pressure
Study 19407805 — Surrogate Endpoint (SUR): Blood pressure
Study 26844281 — Predictive Biomarker (PRD): SOD3 mRNA
Genes: SOD3
Study 16750125 — Surrogate Endpoint (SUR): Blood pressure
Study 9134643 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8185424 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8185424 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 26291918 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 24881463 — Predictive Biomarker (PRD): Hormone receptor
Study 22237064 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22237064 — Predictive Biomarker (PRD): GIPR mRNA
Genes: GIPR
Study 20051257 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 20051257 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 20541286 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 20541286 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 8111802 — Surrogate Endpoint (SUR): Serum potassium
Study 2427858 — Surrogate Endpoint (SUR): Blood pressure
Study 20392890 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 20392890 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 1365868 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study 25643511 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 15689407 — Surrogate Endpoint (SUR): Serum calcium
Study 8607674 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 18028119 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study 15385923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 11125238 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 11806464 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11806464 — Surrogate Endpoint (SUR): Blood pressure
Study 29248384 — Surrogate Endpoint (SUR): Blood pressure
Study 27640138 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 1958005 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 23013746 — Surrogate Endpoint (SUR): Forced vital capacity
Study 20128370 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 17541390 — Surrogate Endpoint (SUR): Blood pressure
Study 17541390 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 825076 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 23904396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23904396 — Surrogate Endpoint (SUR): Blood pressure
Study 23904396 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 17940545 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7996960 — Surrogate Endpoint (SUR): Forced vital capacity
Study 3414518 — Surrogate Endpoint (SUR): Blood pressure
Study 29859917 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29859917 — Predictive Biomarker (PRD): ASIC2 mRNA
Genes: ASIC2; ACCN; ACCN1; BNAC1; MDEG
Study 29859917 — Safety Biomarker (SAF): BDNF
Study 27792869 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8162750 — Surrogate Endpoint (SUR): Blood pressure
Study 28658082 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25528496 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 25528496 — Predictive Biomarker (PRD): PIK3R1 mRNA
Genes: PIK3R1; GRB1
Study 25528496 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 8576779 — Surrogate Endpoint (SUR): Blood pressure
Study 21521539 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25727486 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 25727486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18325143 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11479481 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31178359 — Surrogate Endpoint (SUR): Blood pressure
Study 24617226 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21835486 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 21835486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 12531578 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12531578 — Surrogate Endpoint (SUR): Serum creatinine
Study 10233213 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 30902044 — Surrogate Endpoint (SUR): Bone mineral density
Study 10780771 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 6837082 — Surrogate Endpoint (SUR): Blood pressure
Study 27455399 — Surrogate Endpoint (SUR): Blood pressure
Study 24966007 — Surrogate Endpoint (SUR): Blood pressure
Study 30358417 — Surrogate Endpoint (SUR): Serum uric acid
Study 30358417 — Surrogate Endpoint (SUR): Serum creatinine
Study 11408002 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 14759446 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 12872052 — Surrogate Endpoint (SUR): Blood pressure
Study 12872052 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12872052 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2508341 — Surrogate Endpoint (SUR): Blood pressure
Study 189328 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 31234927 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25969155 — Predictive Biomarker (PRD): EMP1 mRNA
Genes: EMP1; B4B; TMP
Study 12665918 — Monitoring Biomarker (MOI): HBV DNA
Study 28945850 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25784519 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 22626867 — Predictive Biomarker (PRD): HPSE mRNA
Genes: HPSE; HEP; HPA; HPA1; HPR1; HPSE1; HSE1
Study 17700043 — Surrogate Endpoint (SUR): Blood pressure
Study 11483846 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 28686199 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16760409 — Monitoring Biomarker (MOI): Macrophage inflammatory protein 1-alpha
Genes: CCL3; G0S19-1; MIP1A; SCYA3
Study 16760409 — Monitoring Biomarker (MOI): C-C motif chemokine 4
Genes: CCL4; LAG1; MIP1B; SCYA4
Study 14735686 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study 9123739 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 9123739 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 26086689 — Surrogate Endpoint (SUR): Blood pressure
Study 20584260 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 20584260 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 17354241 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 15716285 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 15716285 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 15716285 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9468739 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 9468739 — Predictive Biomarker (PRD): LTB mRNA
Genes: LTB; TNFC; TNFSF3
Study 25910889 — Surrogate Endpoint (SUR): Blood pressure
Study 23306077 — Surrogate Endpoint (SUR): Blood pressure
Study 18503398 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 12905468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9336364 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 29143161 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 7681894 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7681894 — Surrogate Endpoint (SUR): Blood pressure
Study 3752480 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 3752480 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26420590 — Surrogate Endpoint (SUR): Blood pressure
Study 26420590 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 23743397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21649830 — Predictive Biomarker (PRD): ACP7 mRNA
Genes: ACP7; PAPL; PAPL1
Study 15536462 — Surrogate Endpoint (SUR): Blood pressure
Study 9232213 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 26331608 — Predictive Biomarker (PRD): CYP21A2 mRNA
Genes: CYP21A2; CYP21; CYP21B
Study 30290902 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 25209438 — Predictive Biomarker (PRD): TRPV6 mRNA
Genes: TRPV6; ECAC2
Study 25209438 — Surrogate Endpoint (SUR): Bone mineral density
Study 22220931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22220931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22220931 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28705181 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21182509 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 17511722 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 8275737 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25545540 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22562973 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 22562973 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18446847 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 16946216 — Surrogate Endpoint (SUR): Blood pressure
Study 9135961 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 8212369 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 3096035 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 3096035 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 26586786 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 26586786 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 2139413 — Surrogate Endpoint (SUR): Blood pressure
Study 22504653 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 22504653 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 16344839 — Surrogate Endpoint (SUR): Blood pressure
Study 15905753 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8822756 — Surrogate Endpoint (SUR): Blood pressure
Study 8822756 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 29300423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 26427866 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26427866 — Surrogate Endpoint (SUR): Blood pressure
Study 1835850 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 27419081 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23824624 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 23824624 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 20726255 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study 25453457 — Surrogate Endpoint (SUR): Blood pressure
Study 22307842 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 22307842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15920225 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 28239939 — Predictive Biomarker (PRD): FFAR1 mRNA
Genes: FFAR1; GPR40